Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients B… (NCT06766058) | Clinical Trial Compass
RecruitingNot Applicable
Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.
Singapore300 participantsStarted 2024-10-22
Plain-language summary
ASTER is a multi-part study that aims to prospectively establish evidence for the implementation of aromatherapy as complementary therapy within cancer care in the Singapore context. ASTER 2 study evaluates how extracts from Asian aromatic plants with familiar aromas introduced as inhalation therapy can alleviate distress in breast cancer patients scheduled to undergo radiotherapy (RT).
Who can participate
Age range
21 Years – 99 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Aged 21 years old and above
. Confirmed diagnosis of breast cancer of any stage
. Scheduled to undergo radiotherapy for the first time
. Capable of providing informed consent
Exclusion criteria
. Physically or mentally incapable of providing verbal/written consent
. Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations
. Airway hypersensitivity to fragrances, paint fumes or turpentine
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The impact of Inhalation Aromatherapy Intervention on Distress.
Timeframe: Baseline (on CT Simulation Day), Before Intervention (on RT day), and After 20 minutes of Aromatherapy Intervention (on RT day).
2
The impact of Inhalation Aromatherapy Intervention on Anxiety.
Timeframe: Baseline (on CT Simulation Day), After 20 minutes of Aromatherapy Intervention (on RT day).
3
The impact of Inhalation Aromatherapy Intervention on Cortisol (stress hormones).
Timeframe: Before Intervention (on RT day), After 20 minutes of Aromatherapy Intervention (on RT day).